GlobeNewswire Press

  1. Icagen Announces Lifting Of Partial Clinical Hold Of ICA-105665 8/4/2009
    Icagen, Inc. (Nasdaq:ICGN) reported today that the FDA has lifted the partial clinical hold related to the development of ICA-105665, the Company's novel orally available small molecule KCNQ potassium channel agonist, for the treatment of epilepsy.
  2. Generex Publishes Results From Pre-Clinical Studies On Immunotherapeutic Vaccine For HPV-Induced Cervical Cancer 7/23/2009
    Generex Biotechnology Corporation announced today publication of studies demonstrating the anti-cancer activity of a novel Ii-Key/HPV immunotherapeutic vaccine.
  3. Myriad Pharmaceuticals, Inc. Established As An Independent Pharmaceutical Development Company 7/2/2009
    Myriad Pharmaceuticals, Inc. (MPI) today announced that it has completed its previously announced spin-off from Myriad Genetics, Inc. as of 11:59 p.m. last evening.